EFFECT OF AN UNANI REGIMEN IN THE TREATMENT OF 'YARAQĀN' (JAUNDICE): A CASE REPORT

A. Ansari, N. Z. Ahmed, Noman Anwar, Mohammed Farhan K.
{"title":"EFFECT OF AN UNANI REGIMEN IN THE TREATMENT OF 'YARAQĀN' (JAUNDICE): A CASE REPORT","authors":"A. Ansari, N. Z. Ahmed, Noman Anwar, Mohammed Farhan K.","doi":"10.53390/ijum.2022.15203","DOIUrl":null,"url":null,"abstract":"Jaundice due to hepatitis viruses is considered to be a most prevalent disease worldwide. In Unani literature, it is referred as 'yaraqān' which is caused by inflammatory diseases of liver, intra or extra-hepatic obstructions, and poisoning due to drugs or animals. Several Unani drugs including Ma'jun Dabid al-Ward, syrup Jigreen, Araq-iMako, Araq-i-Kasni, etc are frequently used for the treatment of jaundice and liver disorders including infective hepatitis. A 16 year old male patient suffering from yellowish discoloration of sclera, skin, mucous membranes and urine, nausea, vomiting, loss of appetite and fever for one week admitted in the male ward of RRIUM, Chennai. The laboratory investigations revealed severe hyperbilirubinemia, raised serum transaminases, alkaline phosphatase and negative HBsAg. On the basis of history, clinical observations and laboratory investigations, the patient was diagnosed as a case of 'yaraqān' (jaundice) which may be due to acute viral hepatitis. A Unani regimen comprising Ma'jun Dabid al-Ward (5 g twice a day), syrup Jigreen (10 ml twice a day), Araq-i-Mako (75 ml twice a day), Araq-iKasni (75 ml twice a day) for 25 days, Sharbat-i-Khaksi (10 ml twice a day for 7 days), and Habb-i-Tursh Mushtahi (1 g twice a day) for 15 days were given by oral route. The fever has subsided after 7 days and the appetite improved after 15 days of the treatment. The yellow discoloration of sclera and mucous membranes started to reduce gradually th from 7 day onwards. At the end of the treatment, the laboratory reports revealed that the total bilirubin, direct bilirubin, indirect bilirubin, SGOT, SGPT and ALP were within normal range. The core objective of this case report is to re-emphasize the effectiveness of Unani medicine particularly in the treatment of jaundice. Thus, this data may be helpful to increase awareness amongst the common people and scientific community for the popularity of Unani medicine in general and for the treatment of jaundice and liver disorders in particular.","PeriodicalId":13351,"journal":{"name":"Indian Journal of Unani Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Unani Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53390/ijum.2022.15203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Jaundice due to hepatitis viruses is considered to be a most prevalent disease worldwide. In Unani literature, it is referred as 'yaraqān' which is caused by inflammatory diseases of liver, intra or extra-hepatic obstructions, and poisoning due to drugs or animals. Several Unani drugs including Ma'jun Dabid al-Ward, syrup Jigreen, Araq-iMako, Araq-i-Kasni, etc are frequently used for the treatment of jaundice and liver disorders including infective hepatitis. A 16 year old male patient suffering from yellowish discoloration of sclera, skin, mucous membranes and urine, nausea, vomiting, loss of appetite and fever for one week admitted in the male ward of RRIUM, Chennai. The laboratory investigations revealed severe hyperbilirubinemia, raised serum transaminases, alkaline phosphatase and negative HBsAg. On the basis of history, clinical observations and laboratory investigations, the patient was diagnosed as a case of 'yaraqān' (jaundice) which may be due to acute viral hepatitis. A Unani regimen comprising Ma'jun Dabid al-Ward (5 g twice a day), syrup Jigreen (10 ml twice a day), Araq-i-Mako (75 ml twice a day), Araq-iKasni (75 ml twice a day) for 25 days, Sharbat-i-Khaksi (10 ml twice a day for 7 days), and Habb-i-Tursh Mushtahi (1 g twice a day) for 15 days were given by oral route. The fever has subsided after 7 days and the appetite improved after 15 days of the treatment. The yellow discoloration of sclera and mucous membranes started to reduce gradually th from 7 day onwards. At the end of the treatment, the laboratory reports revealed that the total bilirubin, direct bilirubin, indirect bilirubin, SGOT, SGPT and ALP were within normal range. The core objective of this case report is to re-emphasize the effectiveness of Unani medicine particularly in the treatment of jaundice. Thus, this data may be helpful to increase awareness amongst the common people and scientific community for the popularity of Unani medicine in general and for the treatment of jaundice and liver disorders in particular.
unani方案治疗“yaraqĀn”(黄疸)的效果:一例报告
由肝炎病毒引起的黄疸被认为是世界范围内最普遍的疾病。在乌纳尼文献中,它被称为" yaraqān ",是由肝脏炎症、肝内或肝外阻塞以及药物或动物中毒引起的。几种Unani药物,包括Ma'jun Dabid al-Ward、jiggreen糖浆、Araq-iMako、Araq-i-Kasni等,经常用于治疗黄疸和包括传染性肝炎在内的肝脏疾病。一名16岁男性患者,因巩膜、皮肤、粘膜和尿液变黄,恶心、呕吐、食欲不振和发烧一周,住在金奈RRIUM男性病房。实验室检查显示严重的高胆红素血症,血清转氨酶、碱性磷酸酶升高,HBsAg阴性。根据病史、临床观察和实验室调查,诊断为“yaraqān”(黄疸),可能由急性病毒性肝炎引起。Unani方案包括Ma'jun Dabid al-Ward(每天5克两次)、jiggreen糖浆(每天10毫升两次)、Araq-i-Mako(每天75毫升两次)、Araq-iKasni(每天75毫升两次),连续25天、sharbati - khaksi(每天10毫升两次,连续7天)和habbi - tursh Mushtahi(每天1克两次),连续15天。治疗7天后发热消退,治疗15天后食欲改善。巩膜和粘膜的黄变从7天开始逐渐减少。治疗结束时,实验室报告显示总胆红素、直接胆红素、间接胆红素、SGOT、SGPT、ALP均在正常范围内。本病例报告的核心目标是再次强调Unani药物的有效性,特别是在治疗黄疸方面。因此,这些数据可能有助于提高普通民众和科学界对普遍普及乌纳尼医学的认识,特别是对黄疸和肝脏疾病治疗的认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信